Amphotericin Liposomal Sun
- Recalling firm
- Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
- Product
- Amphotericin Liposomal SUN. [Medicine]. Form: Powder for injection 50 mg. Affected: BAH0101A
- Reason
- Boucher & Muir (New Zealand) Ltd. t/a BNM Group, the marketing authorization holder of Amphotericin Liposomal SUN, is conducting a recall of batch BAH0101A, following an overseas product quality complaint involving the presence of a glass particle in a single vial from this batch.
- Classification
- Class I
- Category
- drug recall
- Country
- New Zealand
- Agency
- MEDSAFE
- Recall date
- 2026-07-27
- Status
- Ongoing
- Distribution
- New Zealand - Hospital/Pharmacy/Laboratory
Official recall notice from MEDSAFE
Recall details on Nibble Recalls: https://trynibble.app/recalls/80b6dbda-9847-4c88-b243-9cb035fdafc9